COPD Trial, Recruiting NCT07509606 Sponsor: National Cheng Kung University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07509606
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For Healthy Individuals

Who might be able to join this trial:

  • People who have never tried whole-body vibration therapy before and have never worked in a job or played a sport that regularly exposes them to vibration.
  • People aged between 18 and 65 years.

Who may not be able to join:

  • People who are pregnant.
  • People who have a blood clot (acute thrombosis).
  • People with serious heart or blood vessel disease.
  • People who have a cardiac pacemaker (a device implanted to help regulate heartbeat).
  • People with recent wounds from an injury or surgery.
  • People who have an artificial hip or knee joint.
  • People with an acute hernia, disc problems in the spine, or a specific spinal bone condition called spondylolysis.
  • People with severe diabetes.
  • People with epilepsy.
  • People with a recent infection.
  • People who experience severe migraines.
  • People who have a tumour.
  • People who have recently had an intrauterine device (IUD), metal pins, or metal plates implanted.
  • People with kidney stones.
  • People with organ failure.
  • People living with a musculoskeletal, breathing, neurological, or heart and blood vessel condition, or any form of ongoing or recent pain.
  • People who are currently taking part in another research study.
  • People who already exercise regularly at a moderate intensity three or more times per week.

For People with COPD (Chronic Obstructive Pulmonary Disease)

Who might be able to join this trial:

  • People who have been formally diagnosed with COPD and are classified as GOLD stage II, III, or IV (a medical staging system for COPD severity — confirm with trial site if unsure of stage).
  • People who have not been hospitalised in the past two months.
  • People who have not taken part in any rehabilitation programme in the past two months.
  • People who are able to participate in an exercise training programme.
  • People aged 18 years or older.

Who may not be able to join:

  • People who have another serious lung condition, such as bronchiectasis, pulmonary fibrosis, asthma, or tuberculosis.
  • People who currently smoke.
  • People who have an artificial hip or knee joint.
  • People with severe joint disease or a history of surgery on the lower limbs.
  • People with a history of bleeding inside the eye (vitreous haemorrhage).
  • People who rely on supplemental oxygen to breathe.
  • People who drink heavily (more than 80 grams of alcohol per day).
  • People with severe malnutrition, defined as a BMI below 19 kg/m².
  • People who are pregnant.
  • People who have a blood clot (acute thrombosis).
  • People who have a cardiac pacemaker (a device implanted to help regulate heartbeat).
  • People with recent wounds from an injury or surgery.
  • People with an acute hernia, disc problems in the spine, or a specific spinal bone condition called spondylolysis.
  • People with severe diabetes.
  • People with epilepsy.
  • People with a recent infection.
  • People who experience severe migraines.
  • People who have a tumour.
  • People who have recently had an intrauterine device (IUD), metal pins, or metal plates implanted.
  • People with kidney stones.
  • People with organ failure.
  • People who have altered consciousness or who would be unable to follow the study assessments.
  • People who are currently taking part in another research study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kun-Ling Tasi, PhD, Department of Physical Therapy, National Cheng Kung University

Phone: 886-6-2353535 Ext.5078

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cheng Kung University
Registry
ClinicalTrials.gov
Start date
7 April 2025
Est. completion
8 May 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Pulmonary function test; Diaphragm excursion and thickness; Respiratory muscle strength; cardiopulmonary response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov